SJS Investment Consulting’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
SJS Investment Consulting's IRMD Position: Q3 2026 in Review
SJS Investment Consulting increased its iRadimed (IRMD) stake by 50% in Q3 2026, buying an estimated $90 and bringing the position to 3 shares worth $259. The position accounts for ﹤0.01% of the portfolio, ranked #2896.
SJS Investment Consulting first reported a position in IRMD in Q4 2025 and has held it in 4 quarters since. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- SJS Investment Consulting held 3 shares of iRadimed worth $259 as of Q3 2026.
- SJS Investment Consulting bought 1 iRadimed share in Q3 2026, an estimated $90.
- iRadimed made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2896 holding.
- SJS Investment Consulting first reported a position in iRadimed in Q4 2025 and has held it in 4 quarters since.
- 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.